文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

住院老年患者停用抗胆碱能药物:一项系统评价

Deprescribing Anticholinergic Medications in Hospitalised Older Adults: A Systematic Review.

作者信息

Griffiths Rhianna, Lim Steve, Lin Julian, Bates Andrew, Jones Liam, Ibrahim Kinda

机构信息

Faculty of Medicine, University of Southampton, Southampton, UK.

NIHR Applied Research Collaboration Wessex, University of Southampton, Southampton, UK.

出版信息

Basic Clin Pharmacol Toxicol. 2025 Oct;137(4):e70103. doi: 10.1111/bcpt.70103.


DOI:10.1111/bcpt.70103
PMID:40887761
Abstract

BACKGROUND: Anticholinergic medication use is increasing, particularly among older adults due to polypharmacy and comorbidities. High anticholinergic burden is linked to adverse outcomes such as reduced mobility and increased dementia risk. Acute hospital stays may offer an opportunity to address this often-overlooked issue. AIMS: To examine the effects of deprescribing anticholinergic medications on outcomes in older hospitalised patients. METHODS: Medline, Web of Science, Cochrane Library and Embase were searched from inception to September 2024. Studies included hospital-based deprescribing or medication review interventions targeting anticholinergic burden in patients aged ≥ 65 years. Narrative synthesis followed SWiM guidelines, with quality assessment using JBI Checklists. RESULTS: From 2042 records, eight studies met inclusion criteria. Designs included cohort (n = 4) and pre-post quasi-experimental (n = 4), with follow-up durations of up to 3 months. All reported medication-related outcomes; four assessed acceptability, one included clinical outcomes, and none examined safety. Six studies reported reductions in anticholinergic burden scores; three showed significant decreases in the proportion of patients prescribed anticholinergics, and two noted fewer potentially inappropriate medications. Most recommended changes were implemented. CONCLUSION: Deprescribing interventions in hospital appear acceptable and effective in reducing anticholinergic burden. However, evidence on clinical outcomes, costs and safety is limited. Further RCTs with longer follow-up are needed.

摘要

背景:抗胆碱能药物的使用正在增加,尤其是在老年人中,这是由于多重用药和合并症所致。高抗胆碱能负担与诸如活动能力下降和痴呆风险增加等不良后果相关。急性住院期间可能提供了一个解决这个经常被忽视问题的机会。 目的:研究停用抗胆碱能药物对老年住院患者预后的影响。 方法:检索了从数据库建库至2024年9月的Medline、科学网、考克兰图书馆和Embase。纳入的研究包括针对65岁及以上患者抗胆碱能负担的基于医院的减药或药物审查干预措施。采用SWiM指南进行叙述性综合分析,并使用JBI清单进行质量评估。 结果:从2042条记录中,有8项研究符合纳入标准。研究设计包括队列研究(n = 4)和前后对照准实验研究(n = 4),随访时间长达3个月。所有研究均报告了与药物相关的结局;4项评估了可接受性,1项纳入了临床结局,没有研究考察安全性。6项研究报告抗胆碱能负担评分降低;3项研究显示开具抗胆碱能药物的患者比例显著下降,2项研究指出潜在不适当用药减少。大多数推荐的更改都得到了实施。 结论:医院中的减药干预措施似乎在降低抗胆碱能负担方面是可接受且有效的。然而,关于临床结局、成本和安全性的证据有限。需要进行更长随访期的进一步随机对照试验。

相似文献

[1]
Deprescribing Anticholinergic Medications in Hospitalised Older Adults: A Systematic Review.

Basic Clin Pharmacol Toxicol. 2025-10

[2]
Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment.

Cochrane Database Syst Rev. 2023-12-8

[3]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[4]
Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.

Cochrane Database Syst Rev. 2022-8-22

[5]
Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis.

J Am Geriatr Soc. 2024-10

[6]
Deprescribing in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.

JAMA Netw Open. 2025-5-1

[7]
Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.

Drugs Aging. 2018-4

[8]
Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.

Cochrane Database Syst Rev. 2013-8-21

[9]
Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.

Cochrane Database Syst Rev. 2012-12-12

[10]
Deprescribing versus continuation of chronic proton pump inhibitor use in adults.

Cochrane Database Syst Rev. 2017-3-16

本文引用的文献

[1]
Development and Pilot Testing of an Algorithm-Based Approach to Anticholinergic Deprescribing in Older Patients.

Drugs Aging. 2024-2

[2]
Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment.

Cochrane Database Syst Rev. 2023-12-8

[3]
Interventions for reducing anticholinergic medication burden in older adults-a systematic review and meta-analysis.

Age Ageing. 2023-9-1

[4]
Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study.

Drugs Aging. 2023-7

[5]
Medication Assessment in an Older Population during Acute Care Hospitalization and Its Effect on the Anticholinergic Burden: A Prospective Cohort Study.

Int J Environ Res Public Health. 2023-3-30

[6]
A stewardship program to facilitate anticholinergic and sedative medication deprescribing using the drug burden index in electronic medical records.

Br J Clin Pharmacol. 2023-2

[7]
Effectiveness of Interventions to Improve the Anticholinergic Prescribing Practice in Older Adults: A Systematic Review.

J Clin Med. 2022-1-28

[8]
Increase in anticholinergic burden from 1990 to 2015: Age-period-cohort analysis in UK biobank.

Br J Clin Pharmacol. 2022-3

[9]
Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review.

Int J Clin Pharm. 2021-12

[10]
Associations Between Anticholinergic Medication Exposure and Adverse Health Outcomes in Older People with Frailty: A Systematic Review and Meta-analysis.

Drugs Real World Outcomes. 2021-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索